Diabetes Self-Management Education Core Outcomes Measures

The Diabetes Educator

Volumn 29, Issue 5, 2003, Pages 768-803

  Mulcahy, Kathryn ^a   Maryniuk, Melinda ^b   Peeples, Malinda ^c   Peyrot, Mark ^d   Tomky, Donna ^e   Weaver, Todd ^f   Yarborough, Peggy ^g  

^a Inova Diabetes Center   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Loy Ola College   (United States)

^e Lovelace Sandia Health Systems   (United States)

^f American Association of Diabetes Educators   (United States)

^g Wilson Community Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANTIDEPRESSANT AGENT; GLUCAGON; INSULIN;

BEHAVIOR MODIFICATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; EXERCISE; EYE DISEASE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; OUTCOMES RESEARCH; PATIENT EDUCATION; PATIENT SATISFACTION; REVIEW; SELF CARE; SELF MONITORING; WELLBEING; ATTITUDE TO HEALTH; DIABETIC DIET; EVIDENCE BASED MEDICINE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROBLEM SOLVING; PSYCHOLOGICAL ASPECT; QUALITY CONTROL; STANDARD; TOTAL QUALITY MANAGEMENT;

BENCHMARKING; DIABETES MELLITUS; DIABETIC DIET; EVIDENCE-BASED MEDICINE; EXERCISE; GUIDELINES; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; PROBLEM SOLVING; SELF CARE; TOTAL QUALITY MANAGEMENT;

EID: 1542267436     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170302900509     Document Type: Article

References (101)

1. Mulcahy K, Maryniuk M, Peeples M, et al. Position statement: Standards for Outcomes Measurement of Diabetes Self-Management Education. Diabetes Educ. 2003;29:804-816.
2. Tomky D, Weaver T, Mulcahy K, Peeples M. Diabetes education outcomes: what educators are doing. Diabetes Educ. 2000;26:951-954.
3. American Association of Diabetes Educators. Diabetes Educational and Behavioral Research Summit. Diabetes Educ. 1999;25(suppl).
4. Mensing C, Boucher J, Cypress M, et al. National standards for diabetes self-management education. Diabetes Care. 2002;25(suppl 1): S140-S147.
5. Health Care Finance Administration Medicare program: expanded coverage for outpatient diabetes self-management training and diabetes measurements, 42 Federal Register 410.44 (2000).
6. Agency for Healthcare Research and Quality (formerly the Agency for Health Care Policy and Research). Diabetes outcomes research. Available at: www.AHRQ.gov.
7. Joint Commission on Accreditation of Health Care Organizations. Framework for Improving Performance. Oakbrook Terrace, Ill: Joint Commission on Accreditation of Health Care Organizations; 1994.
8. National Committee for Quality Assurance. Hedis 2003 summary table of measures and product lines. Available at: www.ncqa.org/Programs/HEDIS/Vol22003ListofMeasures.pdf. Accessed 2003.
9. American Diabetes Association Provider Recognition Program. Available at: http://www.diabetes.org. Accessed June 2000.
10. Donebedian A. The Definition of Quality: A Conceptual Exploration. Ann Arbor, Mich: Health Administration Press; 1980.
11. United States Department of Health and Human Services, Agency for Health Care Policy and Research. Washington, DC: US Dept of Health and Human Services; 1995. DHHS publication 95-145.
12. Radosevich DM, Kalambokidis TL, Cords JO, Huber MR, Pruitt MJH. A Practical Guidebook for Implementing, Analyzing, and Reporting Outcomes Measurement. Bloomington, Minn: Stratis Health; 1997.
13. White EB, Sanderson-Austin J. Outcomes measurement: measuring success. Group Pract J. 2000;49:32-34.
14. Mulcahy K. Management of diabetes education programs. In: Franz MJ, ed. A Core Curriculum for Diabetes Education. Diabetes Education and Program Management. 6th ed. Chicago: American Association of Diabetes Educators; 2003.
15. Peeples M, Mulcahy K. Diabetes education outcomes and measurements. AADE News. 1998;24:4-5.
16. Mulcahy K, Peeples M, Tomky D, Weaver T, Upham P. National Diabetes Education Outcomes System: application to practice. Diabetes Educ. 2000;26:957-964.
17. Weaver T. Measuring outcomes: what, when, why, and how. ADA: On the Cutting Edge [newsletter]. 2000;6:6-8.
18. American Association of Diabetes Educators (AADE) Outcomes Measurement Task Force. National Diabetes Education Outcomes System: Diabetes Educator Outcomes Guide. Chicago: American Association of Diabetes Educators; 1999.
19. Peeples M, Mulcahy K, Tomky D, Weaver T. The conceptual framework of the National Ddiabetes Education Outcomes System (NDEOS). Diabetes Educ. 2001;27:547-562.
20. Ratner RE. Longterm health care outcomes in diabetes. Economic and political implications. Endocrinol Metab Clin North Am. 1997;26:487-498.
21. American Diabetes Association Education Recognition Program. Available at: http://www.diabetes.org. Accessed June 2000.
22. Albright A, Franz M, Hornsby G, et al, for the American College of Sports Medicine. Exercise and type 2 diabetes. Position stand. Med Sci Sports Exerc. 2000;32: 1345-1360.
23. Roitman JL, Kelsey M, LaFontain TP, Southard DR, Williams MA, York T, eds. American College of Sports Medicine. Resource Manual for Guidelines for Exercise Testing and Prescription. 3rd ed. Philadelphia: Lea & Febiger; 1998.
24. Durak EP, JovanovicPeterson L, Peterson CM. Randomized crossover study of effect of the resistance training on glycemic control, muscular strength and cholesterol in type 1 diabetic men. Diabetes Care. 1990;13: 1039-1043.
25. Goldberg AP Aerobic and resistive exercise modify risk factors for coronary heart disease. Med Sci Sports Exerc. 1989;21:669-674.
26. American Diabetes Association. Diabetes mellitus and exercise. Clinical practice recommendation. Diabetes Care. 2002;(suppl 1).
27. American Diabetes Association. Implications of the UKPDS. Clinical practice recommendation. Diabetes Care. 2002;(suppl 1).
28. Chin MH, Cook S, Jin L, et al. Barriers to providing diabetes care in community health centers. Diabetes Care. 2001;24:268-274.
29. Joslin's Diabetes Deskbook. Boston: Joslin Diabetes Center; 2001.
30. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB. Studies on the mechanism of improved glycemic control during regular exercise in type 2 diabetes. Diabetologia. 1984;26:355-360.
31. United States Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1996.
32. Franklin BA, Whaley MH, Howley ET, eds. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 6th ed. Baltimore, Md: Williams & Wilkins; 2000.
33. Delehanty L, Halford L. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the DCCT. Diabetes Care. 1993;16: 1453-1458.
34. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25: 608-613.
35. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes-related complications (technical review). Diabetes Care. 2002;25:148-198.
36. Kulkarni K, Castle G, Gregory R, et al. Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes. J Am Diet Assoc. 1998;98:62-70.
37. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 7. Response of fasting plasma glucose to diet therapy in newly presenting type 11 diabetic patients. Metabolism. 1990;39:905-912.
38. Johnson EQ, Thomas M. Medical nutrition therapy by registered dietitians improves HbA1c levels [abstract]. Diabetes. 2001; 50(suppl 2):A21-A21.
39. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2002; 24(suppl 1):S74-S77.
40. Brown SA, Upchurch S, Anding R, Winter M, Ramirez G. Promoting weight loss in type 2 diabetes. Diabetes Care. 1996;19:613-624.
41. American Diabetes Association. Evidencebased nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002;25(suppl 1): S50-S63.
42. American Dietetic Association. Practice guidelines for MNT: Type 1, Type 2, GDM [CDROM]. Chicago: American Dietetic Association; 2002.
43. Chakrapani M, Shenoy D, Gafoor AK. Blood sugar profile in diabetics receiving plain insulin. Indian J Med Sci. 2001;55:263-265.
44. Cunningham MA. Glucose monitoring in type 2 diabetes. Nurs Clin North Am. 2001; 36:361-374.
45. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care. 2002;25: S97-S99.
46. Cox DJ, GonderFrederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001;24:637-642.
47. Cox D, Clarke W, Gonder-Frederick L, Kovatchev B. Driving mishaps and hypoglycaemia: risk and prevention. Int J Clin Pract. 2001;123(suppl):38-42.
48. Franciosi M, Pellegrini F, De Berardis G, et al, QuED Study Group. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care. 2001; 24:1870-1877.
49. Harris Ml. National Health and Nutrition Examination Survey (NHANES 111). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979-982.
50. American Diabetes Association. Self-monitoring of blood glucose (consensus statement). Diabetes Care. 1994;17: 81-89.
51. Kabadi UM, O'Connell KM, Johnson J, Kabadi M. The effect of recurrent practice at home on the acceptability of capillary blood glucose readings. Accuracy of self blood glucose testing. Diabetes Care. 1994;17:1110-1123.
52. The National Steering Committee for Quality Assurance in Capillary Blood Glucose Monitoring. Proposed strategies for reducing user error in capillary blood glucose monitoring. Diabetes Care. 1993;16:493-498.
53. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477-483.
54. Jones PM, Remley C, Engberg RA. Development and testing of the barriers to self-monitoring blood glucose scale. Diabetes Educ. 1996;22: 609-616.
55. United States Pharmacopoeia (USP). Medication counseling behaviors guidelines. In: Klasco RK, ed. USP Drug Information for the Healthcare Professional. Vol 1. Greenwood Village, Colo: Micromedex; 2002.
56. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
57. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
58. Reichard E, Nilsson BY, Rosenqvist V. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993; 329:304-309.
59. Fanale JE, Kronholm P The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150: 841-845.
60. Anastacio CJ. HIV and tuberculosis: noncompliance revised. J Assoc Nurses AIDS Care. 1995;6:11-23.
61. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979.
62. Morris LS, Schulz RM. Patient compliance: an overview. J Clin Pharm Ther. 1992;17: 283-295.
63. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35: 539-545.
64. Hussar DA. Patient compliance: the ongoing challenges facing pharmacy. Am Druggist. 1994;211: 83-90.
65. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC: Patient empowerment: results of a randomized controlled trial. Diabetes Care. 1995;18:943-949.
66. Davis ED, Vander Meer JM, Yarborough PC, Roth SB: Using solution-focused therapy strategies in empowerment-based education. Diabetes Educ. 1999;25: 249-256.
67. Toobert DJ, Glasgow RE: Problem-solving and diabetes self-care. J Behav Med. 1991;14: 71-85.
68. Paterson B, Thorne S. Expert decision making in relation to unanticipated blood glucose levels. Res Nurs Health. 2000;23:147-157.
69. Hill-Briggs F, Echmendia R. Association of metabolic control with problem-solving skills. Diabetes Care. 2001;24: 959-960.
70. Cook S, Aikens JE, Berry CA, McNabb WL. Development of the diabetes problem-solving measure for adolescents. Diabetes Educ. 2001;27: 865-874.
71. Elasy TA, Ellis SE, Brown A, Pichert JW. A taxonomy for diabetes educational interventions. Patient Educ Counsel. 2001;43: 121-127.
72. Rubin R. Psychosocial assessment. In: Funnell MM, Hunt C, Kulkarni K, Rubin R, Yarborough E, eds. A Core Curriculum for Diabetes Education. 3rd ed. Chicago: American Association of Diabetes Educators; 1998:87-111.
73. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes (technical review). Diabetes Care. 1998;21:2161-2177.
74. Colwell JA. Aspirin therapy in diabetes (technical review). Diabetes Care. 1997;20: 1767-1771.
75. Colwell JA. Aspirin therapy in diabetes is underutilized. Diabetes Care. 2001;24:195-196.
76. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes (technical review). Diabetes Care. 1999;22: 1887-1898.
77. Performance Measurement Coordinating Council (AMA, JCAHO, and NCQA). Coordinated measurement set for adults with diabetes (consensus statement). April 2001. Available at: www.ama-assn.org/ama/pub/category/3798.html.
78. Rubin R, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15: 205-218.
79. Aikens JE, Wallander JL, Bell DS, Cole JA. Daily stress variability, learned resourcefulness, regimen adherence, and metabolic control in type 1 diabetes mellitus: evaluation of a path model. J Consult Clin Psychol. 1992;60: 113-118.
80. Halford WK, Cuddihy S, Mortimer RH. Psychological stress and blood glucose regulation in type 1 diabetic patients. Health Psychol. 1990;9: 516-528.
81. Goetsch VL, VanDorsten B, Pbert LA, Ullrich IH, Yeater RA. Acute effects of laboratory stress on blood glucose in noninsulindependent diabetes. Psychosom Med. 1993; 55:492-496.
82. Hanson CL, Henggeler S, Burghen G. Model of associations between psychosocial variables and healthoutcome measures of adolescents with IDDM. Diabetes Care. 1987;10: 752-758.
83. Carter WR, GonderFrederick LA, Cox DJ, Clarke WL, Scott D. Effect of stress on blood glucose in IDDM. Diabetes Care. 1985;8: 411-412.
84. Peyrot M, McMurry J, Kruger D. A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav. 1999; 40:141-158.
85. Peyrot M. Behavior change in diabetes education. Diabetes Educ. 1999;25:62-73.
86. Peyrot M, Rubin R. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1999;20:585-590.
87. Beck AT, Beamesderfer A. Assessment of depression: the Depression Inventory. Mod Prob Pharmacopsychiatry. 1974;7: 151-169.
88. Radloff LS. The CES-D Scale: a self-report scale for research in the general population. Appl Psychol Measures. 1977;1: 385-401.
89. Zung WWK. A selfrating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
90. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18: 754-760.
91. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association; 1995.
92. Ware JH, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36). 1: Conceptual framework and item selection. Med Care. 1992;30:473-483.
93. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
94. Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-oflife outcomes in the Diabetes Control and Complications Trial. Diabetes Care. 1996;19: 195-203.
95. Boyer JG, Earp JL. The development of an instrument for assessing the quality of life of people with diabetes. Med Care. 1997;35:440-453.
96. Carey MP, Jorgensen RS, Weinstock RS, et al. Reliability and validity of the Appraisal of Diabetes Scale. J Behav Med. 1991;14: 43-51.
97. Sarason IG, Levine HM, Basham RB, Sarason BR. Assessing social support: the Social Support Questionnaire. J Pers Soc Psychol. 1983; 44:127-139.
98. Schafer LC, McCaul KD, Glasgow RE. Supportive and nonsupportive family behaviors: relationships to adherence and metabolic control in persons with type 1 diabetes. Diabetes Care. 1986;9:179-185.
99. Aljasem L, Peyrot M, Wissow L, Rubin R. The relationship of barriers and self-efficacy to selfcare behaviors in type 2 diabetes. Diabetes Educ. 2001;27:393-404.
100. Peyrot M, Rubin R. The effect of self-efficacy and behavioral intentions on self-care improvement following diabetes education [abstract]. Diabetes. 1995; 44(suppl 1):96A-96A.
101. Orne CM, Binik YM. Consistency of adherence across regimen demands. Health Psychol. 1989;8:27-43.